Remove 2013 Remove Data Remove Packaging Remove Pharmaceutical
article thumbnail

Seed To Sale, Traceability: Bio Track & Leaf, The Retailers’ Experience In Washington State

Cannabis Law Report

I n early 2013, Congress began work on the framework of the state’s regulatory system. Tracebility was and is the tracking of Cannabis and Cannabis-infused items and products from “see d to sale”, as directed to Washington and Colorado per the Cole Memo issued in August 2013. PUBLISHER: CANNABIS LAW REPORT.

article thumbnail

Hollister Biosciences Inc. Announces strategic initiatives including a planned rebrand, executive and board updates

Cannabis Law Report

The brand is being created to represent a focused vision towards becoming a leading house of brands with a mission to empower consumers with access and a variety of trusted cannabis packaged goods. Earlier in his career, Mr. Ripshtein oversaw business, sales and tax functions in the Canadian spirits, pharmaceutical and financial sectors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Meet the man budding to smash diabetes with cannabis therapy

Cannabis Law Report

Research has found cannabis can help those diagnosed with either type 1 or 2 diabetes, and those who suffer complications, and a landmark study published in the American Journal of Medicine in 2013 said marijuana compounds can also help control blood sugar. It’s all about access and education,” said Tindall.

Therapy 85
article thumbnail

Cannabis Standards Rely on Transparency, Compliance and Collaboration

Cannabis Law Report

The guidelines below detail some prime facets to consider in order to maintain high quality control standards in the cannabis research space: o Compliance with the Cannabis Act and the MRIA Code of Conduct including referencing the guidelines listed in the Pharmaceutical Research section.

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. Another example of cannabinoid mono therapy is the THC pharmaceutical Marinol. The question is, is there truly a difference? References.

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45